Blumenfeld, Andrew M.
Boyd, James P.
Article History
Received: 1 June 2021
Accepted: 18 February 2022
First Online: 4 March 2022
Declarations
:
: The study was approved by the Institutional Review Board of BioMed IRB, POB 600870, San Diego, CA 92160. (619) 282–9998. wwwBIOMEDIRB.com. Protocol number: “NTI-MIGRAINE”.Each participant completed a comprehensive informed consent. All methods were performed in accordance with the relevant guidelines and regulations.
: Not applicable.
: The author declares that he has no competing interests.